Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation

Author:

Li Cairong1,Li Guanhua1,Tu Sijia1,Bai Xinghua1,Yuan Hong2

Affiliation:

1. Department of Cardiology, First People’s Hospital of Linping District , Hangzhou 311199 , P.R. China

2. Department of Cardiology, First People’s Hospital of Linping District , 369 Yingbin Rd , Hangzhou 311199 , P.R. China

Abstract

Abstract Atrial fibrillation (AF) is a common critical cause of stroke and cardiac dysfunction worldwide with lifetime risks. Viral infection and inflammatory response with myocardial involvement may lead to an increase in AF-related mortality. To dissect the potential sequelae of viral infection in AF patients, especially the coronavirus disease 2019 (COVID-19), based on AF and COVID-19 databases from Gene Expression Omnibus, weighted gene co-expression network analysis was used to identify key genes in heart tissues and peripheral blood mononuclear cells. Here, HSCT, PSMB9, STAT2, and TNFSF13B were identified as common risk genes of AF and COVID-19 patients. Correlation analysis of these genes with AF and COVID-19 showed a positive disease relevance. silencing of STAT2 by small interfering RNA significantly rescued SARS-CoV-2 XBB1.5 pseudovirus-induced cardiac cell contraction dysfunction in vitro. In conclusion, we identified STAT2 may be a novel biomarker of inflammation-related cardiac dysfunction in AF.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Reference53 articles.

1. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453–68. 10.1161/circresaha.114.303211. Epub 2014/04/26. PubMed PMID: 24763464.

2. Heijman J, Algalarrondo V, Voigt N, Melka J, Wehrens XH, Dobrev D, et al. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. Cardiovasc Res. 2016;109(4):467–79. 10.1093/cvr/cvv275. Epub 2015/12/26. PubMed PMID: 26705366; PubMed Central PMCID: PMCPMC4777910.

3. Jering KS, Claggett BL, Pfeffer MA, Granger CB, Køber L, Lewis EF, et al. Prognostic importance of NT-proBNP (N-terminal Pro-B-type natriuretic peptide) following high-risk myocardial infarction in the PARADISE-MI trial. Circ Heart Fail. 2023;16(5):e010259. 10.1161/circheartfailure.122.010259. Epub 2023/05/01. PubMed PMID: 37125529.

4. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199–267. 10.1161/cir.0000000000000041. Epub 2014/04/01. PubMed PMID: 24682347; PubMed Central PMCID: PMCPMC4676081.

5. Rudolph V, Andrié RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med. 2010;16(4):470–4. 10.1038/nm.2124. Epub 2010/03/23. PubMed PMID: 20305660; PubMed Central PMCID: PMCPMC2880896.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3